Literature DB >> 24566097

Earlier initiation of ART and further decline in mother-to-child HIV transmission rates, 2000-2011.

Claire L Townsend1, Laura Byrne, Mario Cortina-Borja, Claire Thorne, Annemiek de Ruiter, Hermione Lyall, Graham P Taylor, Catherine S Peckham, Pat A Tookey.   

Abstract

OBJECTIVES: To analyze mother-to-child HIV transmission (MTCT) rates over time in light of changes in management, demographic, and pregnancy characteristics.
DESIGN: Population-based surveillance data on diagnosed HIV-positive women and their infants are routinely collected in the UK and Ireland.
METHODS: A total of 12486 singleton pregnancies delivered in 2000-2011 were analyzed. HIV infection status was available for 11515 infants (92.2%).
RESULTS: The rate of MTCT declined from 2.1% (17/816) in 2000-2001 to 0.46% (nine of 1975, 95% confidence interval: 0.21-0.86%) in 2010-2011 (trend, P=0.01), because of a combination of factors including earlier initiation of antenatal combination antiretroviral therapy (cART). Excluding 63 infants who were breastfed or acquired HIV postnatally, MTCT risk was significantly higher for all modes of delivery in women with viral load of 50-399  copies/ml (1.0%, 14/1349), compared with viral load of less than 50 copies/ml (0.09%, six of 6347, P<0.001). Among the former (viral load 50-399 copies/ml), the risk of MTCT was 0.26% (two of 777) following elective cesarean section and 1.1% (two of 188) following planned vaginal delivery (P=0.17), excluding in-utero transmissions. MTCT probability declined rapidly with each additional week of treatment initially, followed by a slower decline up to about 15 weeks of cART, with substantial differences by baseline viral load.
CONCLUSION: MTCT rates in the UK and Ireland have continued to decline since 2006, reaching an all-time low of 5 per 1000 in 2010-2011. This was primarily because of a reduction in transmissions associated with late initiation or nonreceipt of antenatal cART, and an increase in the proportion of women on cART at conception.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24566097     DOI: 10.1097/QAD.0000000000000212

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  109 in total

1.  Risks and Benefits of Dolutegravir- and Efavirenz-Based Strategies for South African Women With HIV of Child-Bearing Potential: A Modeling Study.

Authors:  Caitlin M Dugdale; Andrea L Ciaranello; Linda-Gail Bekker; Madeline E Stern; Landon Myer; Robin Wood; Paul E Sax; Elaine J Abrams; Kenneth A Freedberg; Rochelle P Walensky
Journal:  Ann Intern Med       Date:  2019-04-02       Impact factor: 25.391

2.  Missed Opportunities for Preventing Perinatal Transmission of Human Immunodeficiency Virus, Florida, 2007-2014.

Authors:  Mary Jo Trepka; Soumyadeep Mukherjee; Consuelo Beck-Sagué; Lorene M Maddox; Kristopher P Fennie; Diana M Sheehan; Maithri Prabhakar; Dan Thompson; Spencer Lieb
Journal:  South Med J       Date:  2017-02       Impact factor: 0.954

3.  Evolution of antiretroviral therapy services for HIV-infected pregnant women in Cape Town, South Africa.

Authors:  Landon Myer; Tamsin Phillips; Victoria Manuelli; James McIntyre; Linda-Gail Bekker; Elaine J Abrams
Journal:  J Acquir Immune Defic Syndr       Date:  2015-02-26       Impact factor: 3.731

Review 4.  Eye pathologies in neonates.

Authors:  Nyaish Mansoor; Tihami Mansoor; Mansoor Ahmed
Journal:  Int J Ophthalmol       Date:  2016-12-18       Impact factor: 1.779

5.  International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK.

Authors: 
Journal:  J Int AIDS Soc       Date:  2016-10-23       Impact factor: 5.396

6.  Estimated Perinatal HIV Infection Among Infants Born in the United States, 2002-2013.

Authors:  Allan W Taylor; Steven R Nesheim; Xinjian Zhang; Ruiguang Song; Lauren F FitzHarris; Margaret A Lampe; Paul J Weidle; Patricia Sweeney
Journal:  JAMA Pediatr       Date:  2017-05-01       Impact factor: 16.193

Review 7.  Toward a universal antiretroviral regimen: special considerations of pregnancy and breast feeding.

Authors:  Amy L Slogrove; Polly Clayden; Elaine J Abrams
Journal:  Curr Opin HIV AIDS       Date:  2017-07       Impact factor: 4.283

8.  Missed opportunities for prevention of vertical HIV transmission in Canada, 1997-2016: a surveillance study.

Authors:  Ari Bitnun; Terry Lee; Jason Brophy; Lindy M Samson; Fatima Kakkar; Wendy Vaudry; Ben Tan; Deborah M Money; Joel Singer; Laura J Sauvé; Ariane Alimenti
Journal:  CMAJ Open       Date:  2018-05-10

9.  Is There a Higher Risk of Mother-to-child Transmission of HIV Among Pregnant Women With Perinatal HIV Infection?

Authors:  Christopher J Goodenough; Kunjal Patel; Russell B Van Dyke
Journal:  Pediatr Infect Dis J       Date:  2018-12       Impact factor: 2.129

10.  Dose-dependent neurocognitive deficits following postnatal day 10 HIV-1 viral protein exposure: Relationship to hippocampal anatomy parameters.

Authors:  Sylvia Fitting; Kristen A McLaurin; Rosemarie M Booze; Charles F Mactutus
Journal:  Int J Dev Neurosci       Date:  2017-10-27       Impact factor: 2.457

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.